Cholinergic therapy for Down's syndrome

被引：66

作者：

Kishnani, PS

Sullivan, JA

Walter, BK

Spiridigliozzi, GA

Doraiswamy, PM

Krishnan, KRR

机构：

[1] Duke Univ, Med Ctr, Dept Pediat, Down Syndrome Clin, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA

来源：

LANCET | 1999年 / 353卷 / 9158期

关键词：

D O I：

10.1016/S0140-6736(98)05285-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1064 / 1065

页数：2

共 5 条

[1]

Bishop J, 1997, AM J EPIDEMIOL, V145, P134

[2] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease [J].

Rogers, SL ;

Farlow, MR ;

Doody, RS ;

Mohs, R ;

Friedhoff, LT ;

Albala, B ;

Baumel, B ;

Booker, G ;

Dexter, J ;

Farmer, M ;

Feighner, JP ;

Ferris, S ;

Gordon, B ;

Gorman, DG ;

Hanna, G ;

Harrell, LE ;

Hubbard, R ;

Kennedy, J ;

McCarthy, J ;

Scharre, DW ;

Schaerf, F ;

Schneider, L ;

Seltzer, B ;

Siegal, A ;

Stark, SR ;

Strauss, A ;

Walshe, TM .

NEUROLOGY, 1998, 50 (01) :136-145

[3]

Sparrow S. S., 2016, Vineland Adaptive Behavior Scales, VThird

[4] Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome [J].

Teller, JK ;

Russo, C ;

DeBusk, LM ;

Angelini, G ;

Zaccheo, D ;

DagnaBricarelli, F ;

Scartezzini, P ;

Bertolini, S ;

Mann, DMA ;

Tabaton, M ;

Gambetti, P .

NATURE MEDICINE, 1996, 2 (01) :93-95

[5] OCCURRENCE OF NEUROPATHOLOGICAL CHANGES AND DEMENTIA OF ALZHEIMERS-DISEASE IN DOWN SYNDROME [J].

WISNIEWSKI, KE ;

WISNIEWSKI, HM ;

WEN, GY .

ANNALS OF NEUROLOGY, 1985, 17 (03) :278-282

← 1 →